Swayam Prakash Srivastava

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Angiotensin Converting Enzyme

Coronavirus Disease

Network Analysis

Top Venues

Pharmaceuticals (Basel, Switzerland)

British journal of pharmacology

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Swayam Prakash Srivastava
Drugs for Diabetes: From Pharmacology to Clinical Application. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Deepti Mathpal, Tahani Musleh Almeleebia, Kholoud M Alshahrani, Mohammed Y Alshahrani, Irfan Ahmad Ansari, Mohammed Asiri, Mehnaz Kamal, Talha Jawaid, Swayam Prakash Srivastava, Mohd Saeed, Vishal M Balaramnavar
Identification of 3-((1-(Benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrazine-2-carboxylic Acid as a Potential Inhibitor of Non-Nucleosidase Reverse Transcriptase Inhibitors through InSilico Ligand- and Structure-Based Approaches. Molecules (Basel, Switzerland) 26 (17) (2021)
Swayam Prakash Srivastava, Julie Elizabeth Goodwin, Pratima Tripathi, Keizo Kanasaki, Daisuke Koya
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease. International journal of molecular sciences 22 (11) (2021)
Swayam Prakash Srivastava, Rohit Srivastava, Subhash Chand, Julie Elizabeth Goodwin
Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Swayam Prakash Srivastava, Julie Elizabeth Goodwin, Keizo Kanasaki, Daisuke Koya
Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease. British journal of pharmacology 177 (16) (2020)